This combination was able to enhance tumor recruitment and activation of CD8+ T cells, reduce M2 macrophage populations, and remodel collagens in the TME, resulting in effective tumor control in murine models, which was not achievable with the individual components of the combination. This evidence concerns the gene CD8A and neoplasm.